Cerebral venous sinus thrombosis in infancy and childhood: Role of genetic and acquired risk factors of thrombophilia

European Journal of Pediatrics

Volumn 157, Issue 7, 1998, Pages 555-560

  Vielhaber, H ^a   Ehrenforth, S ^b   Koch, H G ^a   Scharrer, I ^b   Van Der Werf, N ^a   Nowak Gottl U ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Antiphospholipid syndrome; Childhood sinus thrombosis; Factor V:Q506; Lipoprotein (a); Protein C

Indexed keywords

ANTITHROMBIN; CARDIOLIPIN ANTIBODY; HEPARIN COFACTOR; HOMOCYSTEINE; IMMUNOGLOBULIN G; LIPOPROTEIN A; PROTEIN C; PROTEIN S;

ANGIOGRAPHY; ARTICLE; BACTERIAL INFECTION; BLOOD VESSEL OCCLUSION; CAVERNOUS SINUS THROMBOSIS; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; INFANT; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN C DEFICIENCY; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOPHILIA;

CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; RISK FACTORS; SINUS THROMBOSIS, INTRACRANIAL; THROMBOPHILIA;

EID: 0031835531     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050877     Document Type: Article

References (50)

1. Andrew M, Paes B, Milner R, Johnston M (1990) Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 12:95-104
2. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L (1992) Maturation of the hemostatic system during childhood. Blood 80:1998-2005
3. Aschka I, Aumann V, Bergmann F, Budde U, Eberl W, Eckhof-Donovan S, Krey S, Nowak-Göttl U, Schobess R, Sutor AH, Wendisch J, Schneppenheim R (1996) Prevalence of factor V Leiden in children with thromboembolism. Eur J Pediatr 155:1009-1014
4. Barron TF, Gusnard DA, Zimmerman RA, Clancy RR (1992) Cerebral venous thrombosis in neonates and children. Pediatr Neurol 8:112-116
5. Bernadi F, Faioni EM, Castoldi E, Lunghi B, Castamann G, Sacchi E, Mannucci PM (1997) A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood 90:1552-1557
6. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, Ronde H de, Velden PA van der, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67
7. Birdwell BG, Yeager R, Whitsett TL (1994) Pseudotumor cerebri. A complication of catheter-induced subclavian vein thrombosis. Arch Intern Med 154:808-811
8. Bom JG van der, Bots ML, Haverkate F, Slagboom E, Meijer P, Jong PTVM de, Hofmann A, Grobbee DE, Kluft C (1996) Reduced response to activated protein C is associated with increased risk for cerebrovascular disease. Ann Intern Med 125:265-269
9. Bousser MG, Chiras J, Bories J, Castaigne P (1985) Cerebral venous thrombosis: a review of 38 cases. Stroke 16:199-213
10. Brey RL, Coull BM (1996) Cerebral venous thrombosis. Role of activated protein C resistance and factor V gene mutation. Stroke 27:1719-1720
11. Castoldi E, Lunghi B, Mingozzi F, Ioannou P, Marchetti G, Bernardi F (1997) New coagulation factor V gene polymorphisms define a single and infrequent mutation in Mediterranean populations and Indians. Thromb Haemost 78:1037-1041
12. Cocharan FB, Packman S (1992) Homocystinuria presenting as sagittal sinus thrombosis. Eur Neurol 33:1-3
13. Debus O, Koch HG, Kurlemann G, Straeter R, Vielhaber H, Weber P, Nowak-Göttl U (1998) Factor V Leidan and genetic defects of thrombophilia in childhood porencephaly. Arch Dis Child Fetal Neonatal Ed 78 (in press)
14. Deschiens MA, Conard J, Horellou M, Ameri A, Preter M, Chedru F, Samama MM, Bousser MG (1996) Coagulation studies, factor V Leiden and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 27:1724-1730
15. Dulli DA, Luzzio CC, Williams EC, Schutta HS (1996) Cerebral venous thrombosis and activated protein C resistance. Stroke 27:1731-1733
16. Galli M, Finazzi G, Barbui T (1997) Antiphospholipid antibodies: predictive values of laboratory tests. Thromb Haemost 78:75-78
17. Gebara BM, Goetting FMG, Wang AM (1995) Durai sinus thrombosis complicating subclavian vein catheterization: treatment with local thrombolysis. Pediatrics 95:138 140
18. Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, Schur PH, Hennekens CH, Stampfer MJ (1992) Anticardiolipin antibodies and the risk for ischaemic stroke and venous thrombosis. Ann Intern Med 117:997-1002
19. Gouault-Heilmann M, Quentin P, Dreyfus M, Gandrille S, Emmerich J, Leroy-Matheron C, Guesnu M (1994) Massive thrombosis of venous cerebral sinuses in a 2-year-old boy with a combined inherited deficiency of antithrombin III and protein C. Thromb Haemost 72:782-783
20. Gurgey A, Mesci L, Renda Y, Olcay L, Kocak N, Erdem G (1996) Factor V Q 506 mutation in children with thrombosis (1996) Am J Hematol 53:37-39
21. Imai WK, Everhart FR, Sanders JM (1982) Cerebral venous thrombosis: report of a case and review of the literature. Pediatrics 70:965-970
22. Kinal ME (1967) Traumatic thrombosis of dural venous sinus in closed head injuries. J Neurosurg 27:142-145
23. Kohlhase B, Vielhaber H, Kehl HG, Kececioglu D, Koch HG, Nowak-Göttl U (1996) Thromboembolism and resistance to activated protein C in children with underlying cardiac disease. J Pediatr 129:677-679
24. Koster T, Rosendaal FR, Ronde H de, Briet E, Vandenbroucke JP, Bertina RM (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342:1503-1506
25. Lee WT, Wang PJ, Young C, Shen YZ (1995) Cerebral venous thrombosis in children. Acta Paed Sin 36:425-30
26. Lockman LA, Mastri A, Priest JR, Nesbit M (1980) Dural venous thrombosis in acute lymphoblastic leukemia. Pediatrics 66:943-947
27. Manco-Johnson MJ, Nuss R, Key N, Moertel C, Jacobson L, Meech S, Weinberg A, Lefkowitz J (1996) Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans. J Pediatr 128:319 323
28. Medlock MD, Olivero WC, Hanigan WC, Wright RM, Winek SJ (1992) Children with cerebral venous thrombosis diagnosed with magnetic resonance imaging and magnetic resonance angiography. Neurosurgery 31:870-876
29. Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF (1989) A potential basis for the thrombotic risk associated with lipoprotein (a). Nature 339:301-303
30. Nowak-Göttl U, Funk M, Mosch G, Wegerich B, Kornhuber B, Breddin HK (1994) Univariate tolerance regions for fibrinogen, antithrombin III, protein C, protein S, plasminogen and a2-antiplasmin in children using the new automated coagulation laboratory (ACL) method. Klin Pädiatr 206:437-439
31. Nowak-Göttl U, Aschka I, Koch HG, Boos J, Dockhorn-Dworniczak B, Deufel T, Jürgens H, Kohlhase B, Kuhn N, Laupert A, Rath B, Wolff JEA, Schneppenheim R (1995) Resistance to activated protein C (APCR) in children with acute lymphoblastic leukaemia - the need for a prospective multicentre study. Blood Coagul Fibrinolysis 6:761-764
32. Nowak-Göttl U, Auberger K, Göbel U, Kreuz W, Schneppenheim R, Vielhaber H, Zenz W, Zieger B (1996) Inherited defects of the protein C anticoagulant system in childhood thrombo-embolism. Eur J Pediatr 155:921 927
33. Nowak-Göttl U, Koch HG, Aschka I, Kohlhase B, Vielhaber H, Kurlemann G, Oleszuk-Raschke K, Kehl HG, Jürgens, H, Schneppenheim R (1996) Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haematol 92:992-998
34. Nowak-Göttl U, Kohlhase B, Vielhaber H, Aschka I. Schneppenheim R, Jürgens H (1996) APC Resistance in neonates and infants: adjustment of the aPTT-based method. Thromb Res 81:665 670
35. Nowak-Göttl U, Sträter R, Dübbers A, Oleszuk-Raschke K, Vielhaber H (1996) Ischaemic stroke in infancy and childhood: role of the Arg 506 to Gln mutation in the factor V gene. Blood Coagul Fibrinolysis 7:684-688
36. Nowak-Göttl U, Debus O, Findeisen M, Kassenböhmer R, Koch HG, Pollmann H, Postler C, Weber P, Vielhaber H (1997) Lipoprotein (a) its role in childhood thromboembolism Pediatrics 99:6/e11
37. Poort SR, Rosendaal F, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698 3703
38. Rees CD (1996) The population genetics of factor V Leiden (arg 506 Gln). Br J Haematol 95:579-586
39. Rich C, Gill JC, Wernick S, Konkol RJ (1993) An unusual cause of cerebral venous thrombosis in a four-year-old child. Stroke 24:603 605
40. Schwab FJ, Peyster RG, Brill CB (1987) CT of cerebral venous sinus thrombosis in a child with homocystinuria. Pediatr Radiol 17:244-245
41. Scotti LN, Goldman RL, Hardman DR, Heinz ER (1974) Venous thrombosis in infants and children. Radiology 112:393 399
42. Sifontes MT, Nuss R, Jacobson LJ, Griffin JH, Manco-Johnson MJ (1996) Thrombosis in otherwise well children with the factor V Leiden mutation. J Pediatr 128:324-328
43. Simioni P, De Ronde H, Prandoni P, Saladini M, Bertina RM, Girolami A (1995) Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. Stroke 26:885 890
44. Stefano V de, Finazzi G, Mannucci PM (1996) Inherited thrombophilia: Pathogenesis, clinical syndromes, and management. Blood 87:3531 3544
45. Stephens PH, Lennox G, Hirsch N, Miller D (1991) Superior sagittal sinus thrombosis after internal jugular vein cannulation. Br J Anaesth 67:476 479
46. Taha JM, Crone KR, Berger TS, Becket WW, Prenger EC (1993) Sigmoid sinus thrombosis after closed head injury in children. Neurosurgery 32:541 546
47. Uttenreuther-Fischer MM, Vetter B, Hellmann C, Otting U, Ziemer S, Hausdorf G, Gaedicke G, Kulozik AE (1997) Paediatric thrombo-embolism: the influence of nongenetic factors and the role of activated protein C resistance and protein C deficiency. Eur J Pediatr 156:277 281
48. Uziel Y, Laxer RM, Blaser S, Andrew M, Schneider R, Silverman ED (1995) Cerebral vein thrombosis in childhood systemic lupus erythematosus. J Pediatr 126:722 727
49. Vielhaber H, Kohlhase B, Koch HG, Kehl HG, Fliedner M, Kececioglu D, Kehrel B, Veltmann H, Vogt J, Nowak-Göttl U (1996) Flush heparin during cardiac catherisation prevents long-term coagulation activation in children without APC-resistance preliminary results. Thromb Res 81:651 656
50. Zuber M, Toulon P, Marnet L, Mas JL (1996) Factor V Leiden mutation in cerebral venous thrombosis. Stroke 27:1721 1723